MONOCYCLIC OR BICYCLIC CARBOCYCLES AND HETEROCYCLES AS FACTOR XA INHIBITORS
申请人:Bristol-Myers Squibb Pharma Company
公开号:EP1337251A1
公开(公告)日:2003-08-27
US6710058B2
申请人:——
公开号:US6710058B2
公开(公告)日:2004-03-23
US6951872B2
申请人:——
公开号:US6951872B2
公开(公告)日:2005-10-04
[EN] MONOCYCLIC OR BICYCLIC CARBOCYCLES AND HETEROCYCLES AS FACTOR XA INHIBITORS<br/>[FR] CARBOCYCLES ET HETEROCYCLES MONOCYCLIQUES OU BICYCLIQUES UTILISES COMME INHIBITEURS DU FACTEUR XA
申请人:BRISTOL MYERS SQUIBB PHARMA CO
公开号:WO2002102380A1
公开(公告)日:2002-12-27
The present application describes monocyclic or bicyclic carbocycles and heterocycles and derivatives thereof of formula I: or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of factor Xa.
Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
申请人:——
公开号:US20020183324A1
公开(公告)日:2002-12-05
The present application describes monocyclic or bicyclic carbocycles and heterocycles and derivatives thereof of Formula I:
1
or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of factor Xa.